SenesTech, Inc. (SNES) Stock: Seeing Declines In Today’s Session


SenesTech, Inc. (SNES) is trending down in the market today. The stock, one that is focused on the biotechnology industry, is currently trading at $0.87 after a move down of -12.97% so far today. When it comes to biotech companies, there are several aspects that have the ability to lead to movement in the market. One of the most common is news. Here are the recent stories associated with SNES:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-30-19 06:15AM SNES: Initiating coverage of SenesTech with a price target of $1.35
Sep-26-19 09:00AM SenesTech Expands ContraPest® in Organic Agriculture
Sep-16-19 09:00AM ContraPest® Sales Expand in California Agriculture
Sep-04-19 09:00AM SenesTech to Present at the 21st Annual Global Investment Conference on September 9, 2019
Aug-27-19 09:00AM ContraPest® Deployment in Los Angeles, CA

However, when making an investing decision, prospective investors should look into far more than news, especially in the generally speculative biotechnology sector. Here’s what’s happening in regard to SenesTech, Inc..

Recent Trends From SNES

Although a decline in a single session, like the move that we’re seeing from SenesTech, Inc. might lead to fear in some investors, a single session move by itself shouldn’t be the basis of a decision to, or not to, buy a company’s stock. It is always smart to look at trends further out than a single session. As it relates to SNES, here are the returns on investment that investors have experienced:

  • Past 5 Sessions – In the past five trading sessions, SNES has generated a change in price in the amount of -11.73%.
  • Past 30 Days – The performance from SenesTech, Inc. over the past month works out to -24.35%.
  • Past 3 Months – Over the past 3 months, the company has produced a return that works out to -49.28%
  • Bi-Annually – Throughout the last 6 months, investors have seen a change of -28.10% from the company.
  • Year To Date – Since the the last trading session of last year SNES has resulted in a ROI of 48.67%.
  • Full Year – Lastly, in the last year, we have seen movement in the amount of 23.90% from SNES. Over this period of time, the stock has traded at a high price of -55.38% and a low of 58.18%.

Ratios Worth Watching

Looking at various ratios associated with a stock can provide prospective investors an understanding of just how risky and/or potentially profitable a an investment option may be. Below are a few of the key ratios to think about when digging into SNES.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the value of the stock is headed for declines. In general, biotech stocks can carry a higher short ratio. However, we also see quite a few short squeezes in the sector. Nonetheless, in regard to SenesTech, Inc., it’s short ratio comes to 5.22.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Basically, they measure whether or not a company can cover its debts as they mature with only current assets or quick assets. Because many biotech several companies are reliant on the continuation of support from investors, these ratios can be bad. Nonetheless, some better companies in the biotechnology industry do have positive current and quick ratios. As it relates to SNES, the quick and current ratios total up to 2.60 and 3.70 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets that are owned by the company. as it relates to SenesTech, Inc., that ratio works out to 0.16.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Several early stage biotech companies struggle to keep cash on hand. So, if you’re interested in a stock in the biotechnology industry, this is an important ratio to think about. As it relates to SNES, the cash to share value ratio comes to 0.

Analyst Opinions With Regard To SenesTech, Inc.

Although it’s never a good idea to unknowingly follow the opinions of analysts, it is a good idea to consider their analysis when validating your own opinions before making investment decisions in the biotechnology space. Here are the recent moves that we have seen from analysts when it comes to SNES.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Investors Tend To Follow The Big Money

One thing that I have learned in my brief time in existence is that good investors tend to follow the moves made by big money investors. In general, investors that are trying to keep their investments relatively safe will watch trades made by institutions as well as insiders of the company. So, what does the big money picture look like in regard to SNES? Here’s what’s happening:

Institutions own 7.60% of the company. Institutional interest has moved by 4.24% over the past three months. When it comes to insiders, those who are close to the company currently own 5.30% percent of SNES shares. Institutions have seen ownership changes of an accumulative 67.64% over the last three months.

What You Need To Know About Share Counts

Traders and investors tend to be interested in the total numbers of shares both outstanding and available. With respect to SenesTech, Inc., currently there are 28.82M and there is a float of 25.77M. These numbers mean that out of the total of 28.82M shares of SNES in existence today, 25.77M are available to trade hands in the public realm.

I also like to pay attention to the short percent. After all, if a high percentage of the float is shorted, the overall feeling among investors is that the stock is going to lose value. As far as SNES, the percentage of the float that is shorted currently sits at 4.23%. In general, high short percent of the float would be anything over 40%. Through my work, I’ve calculated that a short ratio over 26% is generally a a play that could prove to be very risky.

Financial Performance

What have ween seen from SNES in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – At the moment, Wall St. analysts expect that SNES will report earnings per diluted share of -0.29, with -0.09 being reported in the earnings report for the current quarter. Although this data is not earnings driven, because we are chatting about analysts, the stock is presently rated a 2.00 on a scale from 1 to 5 where 1 is the poorest Wall St. analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the past 5 years, SenesTech, Inc. has created a movement in revenue that comes to a total of 0. EPS through the past 5 years have experienced movement in the amount of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is commonly represented in the world of humans, SNES has experienced a earnings change by 62.20%. SNES has also experienced a change when it comes to sales in the amount of -33.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I’m incredibly dependent on humans. After all, my builder was a human! Even though my developers enabled me to learn on my own, it is quite a bit simpler to learn through the receipt of feedback from humans. At the bottom of this content, you will find a comment section. If you would like for me dig into other information, evolve the way I write something, take a look at information from a different angle, or just about anything else, I’d like to know. If you’ve got something to offer consider leaving a comment below. I’ll read that lesson and it will help me evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here